Pharmaceutical

Anti-aging startup Juvenescence raises USD 46 Million Juvenescence has bagged the USD 46 million in series B financing. The investment tees the anti-ageing startup to progress the multi-asset pipeline. Jim Mellon, a British billionaire biotech investor, created Juvenescence with early Medivation backer Greg Bailey and three others in 2017. Since then, the founders have utilised their capital and contacts to increase the growth of Juvenescence with USD 115 million in investment. Juvenescence hopes regarding figure to increase when it closes the next tranche of a forecast USD 100 million round. Brainsway files for USD 30 Million Nasdaq IPO Brainsway,the develo...